Vaccine effectiveness of one, two, and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong: a population-based observational study

BACKGROUND: Hong Kong maintained low circulation of SARS-CoV-2 until a major community epidemic of the omicron (B.1.1.529) sublineage BA.2 began in January, 2022. Both mRNA (BNT162b2 [Fosun Pharma-BioNTech]) and inactivated CoronaVac (Sinovac, Beijing, China) vaccines are widely available; however,...

Descripción completa

Detalles Bibliográficos
Autores principales: McMenamin, Martina E, Nealon, Joshua, Lin, Yun, Wong, Jessica Y, Cheung, Justin K, Lau, Eric H Y, Wu, Peng, Leung, Gabriel M, Cowling, Benjamin J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286709/
https://www.ncbi.nlm.nih.gov/pubmed/35850128
http://dx.doi.org/10.1016/S1473-3099(22)00345-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286709/
https://www.ncbi.nlm.nih.gov/pubmed/35850128
http://dx.doi.org/10.1016/S1473-3099(22)00345-0

Ejemplares similares